Prolonged inhibition of P-glycoprotein after exposure to chemotherapeutics increases cell mortality in multidrug resistant cultured cancer cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prolonged inhibition of P-glycoprotein after exposure to chemotherapeutics increases cell mortality in multidrug resistant cultured cancer cells
Authors
Keywords
Cancer treatment, Chemotherapy, P-glycoproteins, Cancer chemotherapy, Apoptosis, Fluorescence imaging, Prostate cancer, Toxicity
Journal
PLoS One
Volume 14, Issue 6, Pages e0217940
Publisher
Public Library of Science (PLoS)
Online
2019-06-08
DOI
10.1371/journal.pone.0217940
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells
- (2018) Amila K. Nanayakkara et al. Scientific Reports
- Cancer stem cells revisited
- (2017) Eduard Batlle et al. NATURE MEDICINE
- Role of drug transport and metabolism in the chemoresistance of acute myeloid leukemia
- (2016) Jose J.G. Marin et al. BLOOD REVIEWS
- Drug Transporters and Multiple Drug Resistance in the Most Common Pediatric Solid Tumors
- (2016) Doriana Fruci et al. CURRENT DRUG METABOLISM
- Deletions of multidrug resistance gene loci in breast cancer leads to the down-regulation of its expression and predict tumor response to neoadjuvant chemotherapy
- (2016) Nikolai V. Litviakov et al. Oncotarget
- Multiple Drug Transport Pathways through Human P-Glycoprotein
- (2015) James W. McCormick et al. BIOCHEMISTRY
- Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents with refractory solid tumors
- (2015) Elizabeth Fox et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade
- (2015) Rishil J. Kathawala et al. DRUG RESISTANCE UPDATES
- P-glycoprotein and membrane roles in multidrug resistance
- (2015) Ricardo J Ferreira et al. Future Medicinal Chemistry
- The Role of Multidrug Resistance Efflux Pumps in Cancer: Revisiting a JNCI Publication Exploring Expression of the MDR1 (P-glycoprotein) Gene
- (2015) Michael M. Gottesman et al. JNCI-Journal of the National Cancer Institute
- The Role of Multidrug Resistance Efflux Pumps in Cancer: Revisiting a JNCI Publication Exploring Expression of the MDR1 (P-glycoprotein) Gene
- (2015) Michael M. Gottesman et al. JNCI-Journal of the National Cancer Institute
- Multidrug resistance in cancer or inefficacy of neuroactive agents: innovative strategies to inhibit or circumvent the active efflux transporters selectively
- (2014) Barbara Pavan et al. DRUG DISCOVERY TODAY
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- P-glycoprotein Inhibition as a Therapeutic Approach for Overcoming Multidrug Resistance in Cancer: Current Status and Future Perspectives
- (2013) Ziyad Binkhathlan et al. CURRENT CANCER DRUG TARGETS
- The XTT Cell Proliferation Assay Applied to Cell Layers Embedded in Three-Dimensional Matrix
- (2012) Lynn Huyck et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Catalytic Transitions in the Human MDR1 P-Glycoprotein Drug Binding Sites
- (2012) John G. Wise BIOCHEMISTRY
- Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit?
- (2012) Man Yu et al. CANCER AND METASTASIS REVIEWS
- Three Decades of P-gp Inhibitors: Skimming Through Several Generations and Scaffolds
- (2012) A. Palmeira et al. CURRENT MEDICINAL CHEMISTRY
- TRPM8 Ion Channels Differentially Modulate Proliferation and Cell Cycle Distribution of Normal and Cancer Prostate Cells
- (2012) María Ll. Valero et al. PLoS One
- Effects of an Indolocarbazole-Derived CDK4 Inhibitor on Breast Cancer Cells
- (2012) Yuan Sun et al. Journal of Cancer
- Multidrug Efflux Pumps and Cancer Stem Cells: Insights Into Multidrug Resistance and Therapeutic Development
- (2011) K Moitra et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacokinetic evaluation of doxorubicin plasma levels in normal and overweight patients with breast cancer and simulation of dose adjustment by different indexes of body mass
- (2010) Deise Raquel Barpe et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- A Phase I Study of the P-Glycoprotein Antagonist Tariquidar in Combination with Vinorelbine
- (2009) J. Abraham et al. CLINICAL CANCER RESEARCH
- A high density assay format for the detection of novel cytotoxic agents in large chemical libraries
- (2008) David Shum et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started